Quantcast

Latest Aminoglycoside Stories

2014-09-17 08:29:10

CARLSBAD, Calif., Sept. 17, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has earned a $4 million milestone payment from Achaogen, Inc. (NASDAQ: AKAO) associated with the initiation of a Phase 3 study of plazomicin in patients with serious multi-drug resistant (MDR), gram-negative bacterial infections. The Phase 3 study is designed as a superiority study to evaluate the efficacy and safety of plazomicin compared to colistin in patients with...

2014-09-09 23:07:12

Transparency Market Research published a new report "Antibacterial Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Albany, New York (PRWEB) September 09, 2014 An antibacterial drug can be broadly defined as any drug/medicine that inhibits bacterial growth or destroys bacteria in the body. Bacterial infections can often have far reaching health effects on a patient and they show different symptoms based on which...

2014-06-30 08:30:32

SOUTH PLAINFIELD, N.J., June 30, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the initiation of a global confirmatory Phase 3 clinical trial of Translarna(TM) (ataluren), an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF). Nonsense mutations within cystic fibrosis are categorized as Class I mutations, a severe form of CF that results in little or no production of the CFTR protein. The Phase 3 confirmatory trial is...

2014-06-17 23:03:04

New research study “Antibiotics Partnering Terms and Agreements” worked out by CurrentPartnering is now available at MarketPublishers.com. London, UK (PRWEB) June 17, 2014 Antibiotics are antimicrobial compounds, used to treat a broad range of various bacterial infections in humans as well as animals and plants. Antibiotics have saved countess lives since their discovery. Antibiotics are effective against certain fungal and bacterial infections and are also used a treatment for...

2014-05-16 08:26:28

- Data Demonstrate Positive Trends in Lung Function and Pulmonary Exacerbations - SOUTH PLAINFIELD, N.J., May 16, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the results of a Phase 3 study of ataluren in patients with nonsense mutation cystic fibrosis (nmCF) were published in Lancet Respiratory Medicine. The results demonstrated positive trends in both the primary endpoint, lung function as measured by relative change in % predicted FEV(1) (forced...

2014-04-30 08:33:40

Grant Supports Steps Towards Investigational New Drug Filing and Clinical Trials SEATTLE, April 30, 2014 /PRNewswire/ -- Oricula Therapeutics, LLC, a biotech company uniquely positioned to introduce medicines to preserve hearing, announced that it has received a grant of $169,398 through the Small Business Innovation Research Program by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health. The award supports preclinical studies to...

2014-04-09 08:29:28

Secures Intellectual Property Rights SEATTLE, April 9, 2014 /PRNewswire/ -- Oricula Therapeutics, LLC, a biotech company uniquely positioned to introduce medications to preserve hearing, announced that it has secured initial funding and licensed intellectual property from University of Washington. These represent key steps toward achieving the company's vision to commercialize compounds it has developed to prevent certain types of hearing loss. The company's product will be the...

2014-04-08 11:54:54

Resistance to an entire class of antibiotics – aminoglycosides -- has the potential to spread to many types of bacteria, according to new biochemistry research. A mobile gene called NpmA was discovered in E. coli bacteria isolated from a Japanese patient several years ago. Global spread of NpmA and related antibiotic resistance enzymes could disable an entire class of tools doctors use to fight serious or life-threatening infections. Using X-ray crystallography, researchers at Emory...

2014-04-01 13:02:44

Antibiotics being explored for the treatment of cystic fibrosis and muscular dystrophy have the potential to trigger autoimmune disease The code for every gene includes a message at the end of it that signals the translation machinery to stop. Some diseases, such as cystic fibrosis and Duchenne muscular dystrophy, can result from mutations that insert this stop signal into the middle of an essential gene, causing the resulting protein to be truncated. Some antibiotics cause the cell's...

2014-03-26 16:25:09

DUBLIN, March 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/bn9wlv/antibacterial) has announced the addition of the "Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" [http://www.researchandmarkets.com/research/bn9wlv/antibacterial ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) An antibacterial drug is referred to as an...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'